72 Investment Holdings, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001832749

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 5 positions · Total reported value $49.96M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, 72 Investment Holdings, LLC disclosed 5 equity positions with a combined reported value of $49.96M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were PRAX ($22.07M), ANRO ($17.62M), LENZ ($5.78M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, 72 Investment Holdings, LLC opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest 72 Investment Holdings, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

72 Investment Holdings, LLC is an SEC-registered 13F filer. As of Q2 2026 it reported 5 US equity positions with a combined value of $49.96M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 5 positions · $49.96M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 44.2%
  • Average position size: $9.99M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund maintains a conservative stance with a focus on stability, as indicated by the "Hold" actions across all holdings and no new positions added. This suggests a cautious approach to market volatility and a preference for established companies within the healthcare sector. 2. Key Moves: There were no changes in the number of shares or weightings for any of the holdings, indicating a passive rebalancing strategy. The fund did not add or remove any positions, indicating a conservative, buy-and-hold approach. 3. Portfolio Structure: The portfolio is passive in nature, with a strong bias towards healthcare, reflecting the sector allocation of the top holdings. The risk appetite appears moderate, as the fund maintains a diversified position across a small number of holdings, avoiding concentration risk. 4. Per-Holding One-Liner: - PRAX: Precision medicine company; PRAXIS Precision Medicines I is a biotechnology company focused on developing targeted therapies. - ANRO: Neurology company; ALTO Neurosciences is a biotechnology company focused on developing therapies for neurological disorders. - LENZ: Gene therapy company; LENZ Therapeutics is a biotechnology company developing gene therapies for rare genetic diseases. - KRRO: Ophthalmology company; KORRO Bio is a biotechnology company focused on developing therapies for eye diseases. - CRBU: Biotechnology company; CARIBOU Biosciences is a biotechnology company focused on developing novel therapies for cancer and other diseases. 5. One-Sentence Style Summary: The Fund 72 Investment Holdings LLC maintained a stable, passive healthcare portfolio with a conservative rebalancing strategy, focusing on established companies within the sector.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 65.93K $22.07M 44.18%
44.18%
Hold
2 667.78K $17.62M 35.27%
35.27%
Hold
3 1.02M $5.78M 11.57%
11.57%
Hold
4 276.83K $3.65M 7.30%
7.30%
Hold
5 474.07K $834.36K 1.67%
1.67%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 100% R 100% F1 100% (modelled on 2026-Q1; 5/10 hit)

Historical Backtest (10 quarters)

Avg precision 95% · recall 97% · F1 96% · avg rank error 0.9 · Top-10 turnover 4%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 83% 71% 77% KRRO · CRBU · TRDA · TSBX · PRAX · OMGAQ KRRO · LENZ · ANRO · PRAX · CRBU · TSBX · OMGAQ
2024-Q2 100% 100% 100% KRRO · LENZ · ANRO · PRAX · CRBU · TSBX · OMGAQ LENZ · KRRO · ANRO · PRAX · TSBX · CRBU · OMGAQ
2024-Q3 100% 100% 100% LENZ · KRRO · ANRO · PRAX · TSBX · CRBU · OMGAQ LENZ · KRRO · ANRO · PRAX · CRBU · OMGAQ · TSBX
2024-Q4 100% 100% 100% LENZ · KRRO · ANRO · PRAX · CRBU · OMGAQ · TSBX LENZ · KRRO · PRAX · ANRO · CRBU · TSBX · OMGAQ
2025-Q1 86% 100% 92% LENZ · KRRO · PRAX · ANRO · CRBU · TSBX · OMGAQ LENZ · KRRO · PRAX · ANRO · CRBU · TSBX
2025-Q2 100% 100% 100% LENZ · KRRO · PRAX · ANRO · CRBU · TSBX LENZ · KRRO · PRAX · ANRO · CRBU · TSBX
2025-Q3 83% 100% 91% LENZ · KRRO · PRAX · ANRO · CRBU · TSBX LENZ · KRRO · PRAX · ANRO · CRBU
2025-Q4 100% 100% 100% LENZ · KRRO · PRAX · ANRO · CRBU PRAX · LENZ · ANRO · KRRO · CRBU
2026-Q1 100% 100% 100% PRAX · LENZ · ANRO · KRRO · CRBU PRAX · ANRO · LENZ · KRRO · CRBU
2026-Q2 ★ 100% 100% 100% PRAX · ANRO · LENZ · KRRO · CRBU PRAX · ANRO · LENZ · KRRO · CRBU

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did 72 Investment Holdings, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, 72 Investment Holdings, LLC reported 5 equity positions worth $49.96M in aggregate; its largest disclosed positions were PRAX ($22.07M), ANRO ($17.62M), LENZ ($5.78M).

How large is 72 Investment Holdings, LLC's portfolio?

72 Investment Holdings, LLC reported $49.96M of long equity holdings across 5 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is 72 Investment Holdings, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/72-investment/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →